HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Up-regulation of long non-coding RNA THRIL in coronary heart disease: Prediction for disease risk, correlation with inflammation, coronary artery stenosis, and major adverse cardiovascular events.

AbstractOBJECTIVE:
This study aimed to investigate the role of long non-coding RNA (lncRNA) THRIL in coronary heart disease (CHD) patients.
METHODS:
A total of 420 patients who underwent coronary arteriography due to suspected symptoms of CHD were enrolled, in which 220 were diagnosed as CHD and 200 were set as control subjects. LncRNA THRIL in plasma samples of CHD patients and control subjects was detected by reverse transcription-quantitative polymerase chain reaction. Gensini score and biochemical indexes were evaluated in CHD patients and control subjects. Plasma inflammatory cytokines were detected, and major adverse cardiovascular events (MACE) were recorded in CHD patients.
RESULTS:
Both before and after adjustment by age/gender, lncRNA THRIL was increased in CHD patients compared with control subjects (both P < .001), and it well predicted enhanced CHD risk by receiver operating characteristic curves. For coronary artery stenosis, it was positively correlated with Gensini score (P < .001, r = .430). For clinical characteristics, lncRNA THRIL was positively correlated with diabetes mellitus occurrence (P < .001) and fasting blood glucose (FBG) level (P = .029, r = .147). For inflammation, it was positively associated with CRP (P < .001, r = .374), TNF-α (P < .001, r = .249), IL-1β (P = .001, r = .222), IL-8 (P < .001, r = .254), and IL-17 (P = .011, r = .172), while negatively correlated with IL-10 (P < .001, r = -.244). For prognosis, lncRNA THRIL was positively associated with MACE accumulating rate (P = .037) in CHD patients.
CONCLUSION:
Long non-coding RNA THRIL was increased in CHD patients and well predicted elevated CHD risk. Moreover, it was correlated with enhanced coronary stenosis, systematic inflammation, FBG level, and MACE risk in CHD patients.
AuthorsHaijun Qi, Jie Shen, Wenping Zhou
JournalJournal of clinical laboratory analysis (J Clin Lab Anal) Vol. 34 Issue 5 Pg. e23196 (May 2020) ISSN: 1098-2825 [Electronic] United States
PMID31944373 (Publication Type: Journal Article)
Copyright© 2020 The Authors. Journal of Clinical Laboratory Analysis Published by Wiley Periodicals, Inc.
Chemical References
  • Cytokines
  • RNA, Long Noncoding
Topics
  • Aged
  • Cardiovascular Diseases (etiology, genetics)
  • Case-Control Studies
  • Coronary Disease (etiology, genetics)
  • Coronary Stenosis (genetics)
  • Cytokines (blood)
  • Female
  • Gene Expression Regulation
  • Genetic Predisposition to Disease
  • Humans
  • Inflammation (blood, genetics)
  • Male
  • Middle Aged
  • Prognosis
  • RNA, Long Noncoding (genetics)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: